BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Saif MW, Karapanagiotou L, Syrigos K. Genetic alterations in pancreatic cancer. World J Gastroenterol 2007; 13(33): 4423-4430 [PMID: 17724796 DOI: 10.3748/wjg.v13.i33.4423]
URL: https://www.wjgnet.com/1007-9327/full/v13/i33/4423.htm
Number Citing Articles
1
Marcel A. Heinrich, Ahmed M.R.H. Mostafa, Jennifer P. Morton, Lukas J.A.C. Hawinkels, Jai Prakash. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo modelsAdvanced Drug Delivery Reviews 2021; 174: 265 doi: 10.1016/j.addr.2021.04.018
2
Sarah F. Connelly, Beth A. Isley, Cheryl H. Baker, Gary E. Gallick, Justin M. Summy. Loss of tyrosine phosphatase‐dependent inhibition promotes activation of tyrosine kinase c‐Src in detached pancreatic cellsMolecular Carcinogenesis 2010; 49(12): 1007 doi: 10.1002/mc.20684
3
Sanjay Kumar, Rajesh Singh, Manoj K. Mishra. Epigenetic Mechanisms in Cancer2018; : 117 doi: 10.1016/B978-0-12-809552-2.00005-X
4
Maria G. Sacco Casamassima, Colin D. Gause, Seth D. Goldstein, Fizan Abdullah, Avner Meoded, Jeffrey R. Lukish, Christopher L. Wolfgang, John Cameron, David J. Hackam, Ralph H. Hruban, Paul M. Colombani. Pancreatic surgery for tumors in children and adolescentsPediatric Surgery International 2016; 32(8): 779 doi: 10.1007/s00383-016-3925-y
5
Alistair Rice, Armando del Rio Hernandez. The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNAFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00952
6
Evan G. Gomes, Sarah F. Connelly, Justin M. Summy. Targeting the Yin and the YangPancreas 2013; 42(5): 795 doi: 10.1097/MPA.0b013e3182793fd7
7
Aude Legoffic, Ezequiel Luis Calvo, Marc Barthet, Jean-Robert Delpero, Jean Charles Dagom, Juan Lucio Iovanna. Identification of Genomic Alterations Associated with the Aggressiveness of Pancreatic Cancer Using an Ultra-High-Resolution CGH ArrayPancreatology 2009; 9(3): 267 doi: 10.1159/000212092
8
Toshitaka Sakai, Hirosato Mashima, Yumi Yamada, Takashi Goto, Wataru Sato, Takahiro Dohmen, Kentaro Kamada, Masato Yoshioka, Hiroshi Uchinami, Yuzo Yamamoto, Hirohide Ohnishi. The Roles of Interferon Regulatory Factors 1 and 2 in the Progression of Human Pancreatic CancerPancreas 2014; 43(6): 909 doi: 10.1097/MPA.0000000000000116
9
P.V. Anuranjana, Fathima Beegum, Divya K.P, Krupa Thankam George, G.L. Viswanatha, Pawan G. Nayak, Abhinav Kanwal, Anoop Kishore, Rekha R. Shenoy, K. Nandakumar. Mechanisms behind the pharmacological application of biochanin-A: a reviewF1000Research 2023; 12: 107 doi: 10.12688/f1000research.126059.2
10
Jiheum Park, Michael G. Artin, Kate E. Lee, Benjamin L. May, Michael Park, Chin Hur, Nicholas P. Tatonetti. Structured deep embedding model to generate composite clinical indices from electronic health records for early detection of pancreatic cancerPatterns 2023; 4(1): 100636 doi: 10.1016/j.patter.2022.100636
11
Michael A van Geer, Koert FD Kuhlmann, Conny T Bakker, Fibo JW ten Kate, Ronald PJ Oude Elferink, Piter J Bosma. <italic>Ex-vivo</italic> evaluation of gene therapy vectors in human pancreatic (cancer) tissue slicesWorld Journal of Gastroenterology 2009; 15(11): 1359-1366 doi: 10.3748/wjg.15.1359
12
Vikas Bhardwaj, Satya Murthy Tadinada, Aditi Jain, Vikas Sehdev, Christopher K. Daniels, James C.K. Lai, Alok Bhushan. Biochanin A reduces pancreatic cancer survival and progressionAnti-Cancer Drugs 2014; 25(3): 296 doi: 10.1097/CAD.0000000000000044
13
Lukasz Filip Grochola, Helge Taubert, Thomas Greither, Umesh Bhanot, Andrej Udelnow, Peter Würl. Elevated Transcript Levels From the MDM2 P1 Promoter and Low p53 Transcript Levels Are Associated With Poor Prognosis in Human Pancreatic Ductal AdenocarcinomaPancreas 2011; 40(2): 265 doi: 10.1097/MPA.0b013e3181f95104
14
Nicholas Trakul, Albert C. Koong, Daniel T. Chang. The role of adjuvant chemoradiation in the treatment of pancreatic cancerJournal of Radiation Oncology 2013; 2(4): 391 doi: 10.1007/s13566-013-0121-8
15
Mami Takahashi, Mika Hori, Michihiro Mutoh, Keiji Wakabayashi, Hitoshi Nakagama. Experimental Animal Models of Pancreatic Carcinogenesis for Prevention Studies and Their Relevance to Human DiseaseCancers 2011; 3(1): 582 doi: 10.3390/cancers3010582
16
Craig D. Logsdon, Baoan Ji, Rosa F. Hwang. Pancreatic Cancer2010; : 285 doi: 10.1007/978-0-387-77498-5_11
17
Yanli Luo, Ling Tian, Ye Feng, Miaoying Yi, Xiafang Chen, Qian Huang. The Predictive Role of p16 Deletion, p53 Deletion, and Polysomy 9 and 17 in Pancreatic Ductal AdenocarcinomaPathology & Oncology Research 2013; 19(1): 35 doi: 10.1007/s12253-012-9555-3
18
Tatsuo Hata, Masaharu Ishida, Fuyuhiko Motoi, Takuhiro Yamaguchi, Takeshi Naitoh, Yu Katayose, Shinichi Egawa, Michiaki Unno. Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysisPancreatology 2016; 16(3): 372 doi: 10.1016/j.pan.2016.01.007
19
P.V. Anuranjana, Fathima Beegum, Divya K.P, Krupa Thankam George, G.L. Viswanatha, Pawan G. Nayak, Abhinav Kanwal, Anoop Kishore, Rekha R. Shenoy, K. Nandakumar. Mechanisms behind the pharmacological application of biochanin-A: a reviewF1000Research 2023; 12: 107 doi: 10.12688/f1000research.126059.1
20
S. A. Danovi, H. H. Wong, N. R. Lemoine. Targeted therapies for pancreatic cancerBritish Medical Bulletin 2008; 87(1): 97 doi: 10.1093/bmb/ldn027
21
Aude Legoffic, Ezequiel Calvo, Carla Cano, Emma Folch-Puy, Marc Barthet, Jean Robert Delpero, Montse Ferrés-Masó, Jean Charles Dagorn, Daniel Closa, Juan Iovanna, Joy Sturtevant. The reg4 Gene, Amplified in the Early Stages of Pancreatic Cancer Development, Is a Promising Therapeutic TargetPLoS ONE 2009; 4(10): e7495 doi: 10.1371/journal.pone.0007495
22
Lei Cui, Yuezhen Deng, Yefei Rong, Wenhui Lou, Zhengfa Mao, Yuanyuan Feng, Dong Xie, Dayong Jin. IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cellsTumor Biology 2012; 33(1): 247 doi: 10.1007/s13277-011-0273-3
23
Zhiqin Chen, Haifei Song, Xiaochen Zeng, Ming Quan, Yong Gao. Screening and discrimination of optimal prognostic genes for pancreatic cancer based on a prognostic prediction modelG3 Genes|Genomes|Genetics 2021; 11(11) doi: 10.1093/g3journal/jkab296
24
Zhiping Zhang, Zhou Wang, Xiangyan Liu, Jie Wang, Feng Li, Changling Li, Baozhong Shan. Up-regulation of p21WAF1/CIP1 by small activating RNA inhibits the in vitro and in vivo growth of pancreatic cancer cellsTumori Journal 2012; 98(6): 804 doi: 10.1177/030089161209800620
25
Gian Luca Baiocchi, Vincenzo Villanacci, Elisa Rossi, Federico Gheza, Nazario Portolani, Stefano M. Giulini. HER-2/Neu and Topoisomerase-II-α Expression and Genic Amplification in Pancreatic AdenocarcinomaDigestive Diseases and Sciences 2009; 54(9): 2049 doi: 10.1007/s10620-009-0897-y
26
Simone Polvani, Massimo Calamante, Valeria Foresta, Elisabetta Ceni, Alessandro Mordini, Alessandro Quattrone, Massimo D'Amico, Claudio Luchinat, Ivano Bertini, Andrea Galli. Acycloguanosyl 5′-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in MiceGastroenterology 2011; 140(2): 709 doi: 10.1053/j.gastro.2010.10.050
27
Xianwei Wang, Jianfeng Zhao, Jianhua Huang, Huihuan Tang, Shuyi Yu, Yuxiang Chen. The regulatory roles of miRNA and methylation on oncogene and tumor suppressor gene expression in pancreatic cancer cellsBiochemical and Biophysical Research Communications 2012; 425(1): 51 doi: 10.1016/j.bbrc.2012.07.047
28
Alexios Strimpakos, Muhammad W. Saif, Kostas N. Syrigos. Pancreatic cancer: from molecular pathogenesis to targeted therapyCancer and Metastasis Reviews 2008; 27(3): 495 doi: 10.1007/s10555-008-9134-y
29
P.V. Anuranjana, Fathima Beegum, Divya K.P, Krupa Thankam George, G.L. Viswanatha, Pawan G. Nayak, Abhinav Kanwal, Anoop Kishore, Rekha R. Shenoy, K. Nandakumar. Mechanisms Behind the Pharmacological Application of Biochanin-A: A reviewF1000Research 2023; 12: 107 doi: 10.12688/f1000research.126059.3